Target intelligence / Profile preview

GXYLT1 pseudogene 3 (GXYLT1P3)

Target
GXYLT1P3
Molecular classification
Other (Pseudogene)
01

Overview

GXYLT1 pseudogene 3 (GXYLT1P3) is a non-coding pseudogene related to the glucoside xylosyltransferase 1 (GXYLT1) gene. Located in the human genome with NCBI GeneID 100132541, it does not encode a functional protein. Pseudogenes like GXYLT1P3 may affect biology by acting as regulatory RNAs or competitive endogenous RNAs (ceRNAs), but no such function has yet been established for GXYLT1P3 specifically. There is no evidence that it is a therapeutic target or that it interacts with any drugs. The actual targetable and functionally characterized gene is GXYLT1 (glucoside xylosyltransferase 1), not GXYLT1P3. GXYLT1 is a glycosyltransferase enzyme with roles in Notch signaling and certain cancers. GXYLT1P3 is distinguished by the term “pseudogene,” implying it generally does not produce a functional protein and is not considered a therapeutic target. Pseudogenes are sometimes transcribed and can act through RNA-mediated mechanisms, but this is typically rare and not established for GXYLT1P3. If your intent was to inquire about the functionally active enzyme, refer to “glucoside xylosyltransferase 1 (GXYLT1).” If you only want information specific to the pseudogene, as above, note the absence of therapeutic relevance or established function.

02

Biological functions

None established; as a pseudogene, no confirmed protein product or function
03

Disease associations

None directly documented; pseudogenes can have regulatory roles or associations in leukemia, cancer, or other conditions indirectly, but no specific role for GXYLT1P3 is reported

Beyond the preview

Go deeper on GXYLT1 pseudogene 3 (GXYLT1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GXYLT1 pseudogene 3 (GXYLT1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call